| |
SCIENTIFIC DIRECTORS
Ron Lee, MD
Hematopathologist, Flow Cytometry
Dr. Ron Lee, boarded in anatomic and clinical pathology and hematopathology, provides flow cytometric analysis and interpretation. Dr. Lee’s experience, knowledge and customer focus enhances the services we provide to our clients in oncology patient management.
Dr. Lee is a graduate of the University of Florida College of Medicine. He completed an internship in family and community medicine at the University of Kentucky, followed by service in the Air Force as a flight surgeon. After serving in the Air Force, Dr. Lee completed residency training in anatomic and clinical pathology and a fellowship in hematopathology at the University of Florida. Dr. Lee has analyzed all types of samples submitted for flow cytometric evaluation and has seen a wide variety of cases, including minimal residual disease detection. He actively analyzes the raw (list mode) flow data for every case to account for and characterize all cell populations detected by flow cytometry.
Nicholas T. Potter, PhD, FACMG
Chief Scientific Officer /
Director, Molecular Diagnostics Laboratory
Dr. Nicholas Potter is the director of molecular diagnostics and is responsible for providing the medical and scientific expertise required to implement and sustain the growth of Geneuity’s molecular diagnostics and laboratory medicine.
Dr. Potter is a clinical associate professor of pathology at the University of Tennessee Medical Center and has more than 15 years experience in molecular diagnostics. He is a fellow of the American College of Medical Genetics and is board certified in clinical molecular genetics by the American Board of Medical Genetics. He holds certificates of qualification for the New York State Department of Health in genetics, molecular oncology, bacteriology, and virology and is licensed by the state of Tennessee as a laboratory director. Dr. Potter received his bachelor's and master’s degrees from Bucknell University and his doctoral degree from Duke University. |
Elizabeth W. Hubbard, MD
Medical Director
Dr. Elizabeth Hubbard oversees the diagnostic services provided by Geneuity. A graduate of the Medical University of South Carolina, Dr. Hubbard has more than 10 years of diagnostic experience in university and community pathology practice. She is board certified by the American Board of Pathology in anatomic and clinical pathology and cytopathology and is a fellow of the American Society of Clinical Pathologists, the College of American Pathologists, and the International Academy of Pathology, US and Canadian division.
Katy Phelan, PhD, FACMG
Director, Cytogenetics Laboratory
Dr. Katy Phelan is the director of the cytogenetics laboratory. She has more than 20 years experience in cytogenetics and is certified by the American Board of Medical Genetics as a clinical cytogeneticist and as a Ph.D. Medical Geneticist.
Dr. Phelan served as the director of the cytogenetics laboratory at the Greenwood Genetic Center in South Carolina for 17 years and was director of the genetic diagnostic laboratory at T.C. Thompson Children’s Hospital in Chattanooga for five years. In May 1988, while at Greenwood Genetic Center, Phelan discovered the 22q13 Deletion syndrome or the Phelan-McDermid syndrome, a rare genetic anomaly caused by the absence of genes at the tip of the long-arm of chromosome 22.
Dr. Phelan obtained her doctoral degree in human genetics from the Medical College of Virginia in Richmond and is a founding fellow of the American College of Medical Genetics. She is qualified as a laboratory director in cytogenetics by the New York State Department of health and is licensed as a laboratory director by the State of Tennessee.
|
Kelley S. Parman, MS, MT (ASCP) QIHC
Manager, Immunohistochemistry
Kelly Parman leads the immunohistochemistry division and is responsible for expanding the IHC test menu. Parman has 15 years experience in medical technology and management, and her success and expertise in immunohistochemistry is outstanding. Prior to joining Geneuity’s parent company, she developed and directed the Vanderbilt Institutional Immunohistochemistry Core Facility at Vanderbilt University Medical Center in Nashville.
Parman is a licensed medical technologist by the American Society for Clinical Pathology, a certified specialist in immunohistochemistry and a state licensed medical laboratory supervisor. She earned a bachelor’s of art degree from Carson-Newman College and a master’s of science degree from the University of Tennessee, Knoxville.
Rosalynn J. Miltenberger, PhD
Director, Quality Systems
Dr. Rosalynn Miltenberger is responsible for laboratory compliance, quality assurance, control and processes for Geneuity. With more than 20 years biomedical research experience, Dr. Miltenberger has broad training in genetics and cellular, molecular and cancer biology. She received her doctorate from the University of Wisconsin-Madison in the McArdle Laboratory for Cancer Research and was an Alexander Hollander Distinguished Fellow at the Oak Ridge National Laboratory.
Donald Henley
Manager, Clinical Research Services Laboratory
Donald Henley is the manager of the Geneuity’s clinical research services laboratory. He has extensive clinical research experience, including six years of cancer genetics research at the Oak Ridge National Laboratory and several years in cellular signal transduction research in breast cancer cell models at the University of Tennessee Medical Center in Knoxville. Henley has developed and clinically validated several molecular diagnostic assays specifically for use in clinical trials. Henley earned his bachelor and master of science degrees at the University of Tennessee, Knoxville.
|
